Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Familial cerebral cavernous malformation (CCM) is an autosomal-dominant vascular disorder characterized by clusters of dilated capillary cavities in the central nervous system. Positional cloning mapped the CCM1 locus to chromosome 7q21-22 and identified KRIT1 (HGNC:1573) as the disease gene, with seven different loss-of-function mutations in 23 distinct CCM1 families (PMID:10545614).
Genetic evidence for KRIT1-related CCM is robust: over 200 mutation carriers have been documented, including a recurrent founder splice-site mutation c.1146+1G>T and diverse truncating variants. A novel nonsense variant c.2092C>T (p.Gln698Ter) was reported in a Chinese family with five affected members presenting seizures, ataxia, headaches, and cutaneous lesions (PMID:11959162).
The variant spectrum is dominated by splice-donor, frameshift, and nonsense mutations (e.g., c.2092C>T (p.Gln698Ter)), leading to KRIT1 haploinsufficiency. No simple missense variants have been shown to be pathogenic without inducing aberrant splicing, supporting loss of function as the primary mechanism (PMID:11941540).
Segregation analyses across multiple pedigrees demonstrate co-segregation of KRIT1 truncating alleles with CCM phenotypes, albeit with incomplete clinical penetrance; at least 23 additional affected relatives have confirmed segregation of pathogenic KRIT1 variants (PMID:10545614).
Functional studies show that KRIT1 interacts with ICAP1α and the CCM2/CCM3 proteins to regulate integrin β1–mediated endothelial junction stability. Disruption of these interactions impairs endothelial barrier function and promotes lesion formation via a two-hit mechanism in vivo (PMID:11741838).
Integration of genetic and experimental data supports a definitive KRIT1–CCM1 association with CCM, informing presymptomatic testing, family screening, and tailored surveillance strategies. Key take-home: KRIT1 mutation analysis is essential for accurate diagnosis, risk assessment, and management of individuals with familial CCM.
Gene–Disease AssociationDefinitivePositional cloning in 23 families with co-segregation and worldwide replications Genetic EvidenceStrong
Functional EvidenceModerateKRIT1 interaction with ICAP1, CCM2/CCM3, endothelial junction assays and two-hit in vivo models (PMID:11741838) |